We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show counterintuitive results. An AI Insider scoop.
We hope you've had a chance to review the press release we issued after market close in the U.S. today, announcing the positive top-line results of the Phase III ABTECT Maintenance trial. Joining me ...
One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic ...
Play By Play Studios CEO Scott Probst explains what will make ‘NBA The Run’ unique when it launches June 9. Jon Hartzell, NBA ...
Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries from severe long Covid, achieved entirely outside mainstream medicine. The ...
MAIA Biotechnology, Inc. (NYSE American: MAIA) ('MAIA”, the 'Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, delivered a poster ...
An independent, research-informed evaluation of the Bioma probiotic formulation - examining its ingredients, dosage ...
The combination of pharmacotherapy and psychotherapy is associated with reductions in emergency department visits and inpatient admissions along with lower total cost of care relative to either ...
After the sponsor halted the trial, despite the DSMB’s advice to continue, investigators aimed to salvage the scientific value.
Primary care practitioners serve a critical role in optimizing clinical outcomes for adults with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results